Comparing treatment modalities for hepatocellular carcinoma: the value of network meta-analyses

Authors

  • Ronald Chow Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, USA
  • Charles B. Simone II New York Proton Center, Memorial Sloan Kettering Cancer Center, New York, USA
  • Meghan Pooja Jairam Columbia University Vagelos College of Physicians and Surgeons, Columbia University, New York, USA
  • Anand Swaminath Juravinski Cancer Centre, Michael G DeGroote School of Medicine, McMaster University, Hamilton, Canada
  • Gabriel Boldt London Regional Cancer Program, London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Canada
  • Michael Lock London Regional Cancer Program, London Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Canada

DOI:

https://doi.org/10.1080/0284186X.2022.2025613

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2022-04-03

How to Cite

Chow, R., Simone II, C. B., Pooja Jairam, M., Swaminath, A., Boldt, G., & Lock, M. (2022). Comparing treatment modalities for hepatocellular carcinoma: the value of network meta-analyses. Acta Oncologica, 61(4), 495. https://doi.org/10.1080/0284186X.2022.2025613

Issue

Vol. 61 No. 4 (2022): Acta Oncologica

Section

Articles